Katherine N Weilbaecher (Katherine Weilbaecher)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Binding Protein

Machine Learning

Metastatic Breast Cancer

Sentinel Lymph Node

Top Venues

Cancer discovery

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Tri Giang Phan, Katherine N Weilbaecher, Rebecca Aft, Peter I Croucher, Christine L Chaffer
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME. Cancer discovery 14 (4) (2024)
Douglas V Faget, Xianmin Luo, Matthew J Inkman, Qihao Ren, Xinming Su, Kai Ding, Michael R Waters, Ganesh Kumar Raut, Gaurav Pandey, Paarth B Dodhiawala, Renata Ramalho-Oliveira, Jiayu Ye, Thomas Cole, Bhavna Murali, Alexander Zheleznyak, Monica Shokeen, Kurt R Weiss, Joseph B Monahan, Carl J DeSelm, Adrian V Lee, Steffi Oesterreich, Katherine N Weilbaecher, Jin Zhang, David G DeNardo, Sheila A Stewart
p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy. Cancer discovery (2023)
Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PloS one 18 (12) (2023)
Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PloS one 18 (12) (2023)
Andrew A Davis, Jingqin R Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Lu Tan, Rama Suresh, Foluso O Ademuyiwa, Caron Rigden, Timothy P Rearden, Katherine K Clifton, Katherine N Weilbaecher, Ashley Frith, Pavankumar K Tandra, Tracy Summa, Brittney Haas, Shana Thomas, Leonel F Hernandez-Aya, Lindsay L Peterson, Xiaohong Wang, Shujun J Luo, Kemin Zhou, Pan Du, Shidong Jia, Bonnie L King, Jairam Krishnamurthy, Cynthia X Ma
Genomic complexity predicts resistance to endocrine therapy and CDK4/6 inhibition in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PloS one 18 (12) (2023)
Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PloS one 18 (12) (2023)
Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PloS one 18 (12) (2023)
Gregory C Fox, Xinming Su, Jennifer L Davis, Yalin Xu, Kristin A Kwakwa, Michael H Ross, Francesca Fontana, Jingyu Xiang, Alison K Esser, Elizabeth Cordell, Kristen Pagliai, Ha X Dang, Jothilingam Sivapackiam, Sheila A Stewart, Christopher A Maher, Suzanne J Bakewell, James A J Fitzpatrick, Vijay Sharma, Samuel Achilefu, Deborah J Veis, Gregory M Lanza, Katherine N Weilbaecher
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases. Molecular cancer therapeutics 20 (6) (2021)
Jingyu Xiang, Min Shi, Mark A Fiala, Feng Gao, Michael P Rettig, Geoffrey L Uy, Mark G Frattini, Katherine N Weilbaecher, Keith Stockerl-Goldstein, Shamim Mollah, John F DiPersio
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors. Blood advances (2021)